This announcement is a separate document:
康辰药业：北京国枫律师事务所关于北京康辰药业股份有限公司2023年限制性股票激励计划回购注销部分限制性股票的法律意见书
Kangchen Pharmaceutical: Legal Opinion of Beijing Guofeng Law Firm on the 2023 Restricted Stock Incentive Plan of Beijing Kangchen Pharmaceutical Co., Ltd. to repurchase and cancel some restricted stocks
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated